education
Hosted by Ontada Learn · education · EN · 46 episodes
OncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn and community oncologists from The US Oncology Network as they explore oncology with a focus on the latest breakthroughs in cancer care. Expect concise, impactful discussions with practical clinical insights tailored for the real-world community oncology setting. Additionally, don’t miss OncoTalks Case Journeys , where experts deep dive into oncology patient cases and treatment journeys. Join as they conduct comprehensive case reviews, explore key learnings, and discuss the latest research and advances related to each case. Tune into OncoTalks and start unlocking pathways to better patient care today!
Required Pod Score for this show. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
31%
Guest openness
Selective
Sign up to generate a grounded pitch for OncoTalks | Oncology Insights at Your Fingertips.
Signup to Generate a PitchOncoTalks is the podcast for community oncology providers and clinicians who want to stay on top of new treatments and the latest advancements in oncology. Join Ontada Learn and community oncologists from The US Oncology Network as they explore oncology with a focus on the latest breakthroughs in cancer care.
OncoTalks | Oncology Insights at Your Fingertips is hosted by Ontada Learn. The show has published 46 episodes to date.
Recent episodes include "Micro-Series | Part 4 | Beyond Breast Cancer Treatment Selection: Supporting Adherence and Quality of Life" (16 October 2026, 4 minutes), "Micro-Series | Part 3 | Biomarker-Driven Treatment Sequencing in Metastatic Breast Cancer" (16 October 2026, 4 minutes), and "Micro-Series | Part 2 | Choosing a CDK4/6 Inhibitor in Early-Stage Breast Cancer" (16 October 2026, 5 minutes).
OncoTalks | Oncology Insights at Your Fingertips publishes roughly daily, with episodes averaging 6 minutes across 46 episodes.
Booking probability for OncoTalks | Oncology Insights at Your Fingertips is 31%, and the host is rated Selective on guests. OncoTalks | Oncology Insights at Your Fingertips requires a Pod Score of 80 or higher. OncoTalks | Oncology Insights at Your Fingertips's contact route on record: public web form.
The strongest fits for OncoTalks | Oncology Insights at Your Fingertips are Outpatient Clinics. OncoTalks | Oncology Insights at Your Fingertips has an education audience.
Ontada Learn hosts OncoTalks | Oncology Insights at Your Fingertips, an education show with 46 episodes published.
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #55
In this concluding episode, Dr. Mabel Mardones shares practical approaches to managing treatment-related toxicities, supporting adherence, and maintaining quality of life, emphasizing proactive intervention...
Episode #54
In this episode of OncoTalks, Dr. Mabel Mardones examines how endocrine sensitivity, biomarker testing, and evolving resistance biology inform treatment sequencing in metastatic HR-positive/HER2-negative breast cancer...
Episode #53
In this episode of OncoTalks, Dr. Mabel Mardones explains how treatment duration, toxicity profiles, and patient-specific factors can inform CDK4/6 inhibitor selection in early-stage HR-positive/HER2-negative breast...
Episode #52
In this episode of OncoTalks, Dr. Mabel Mardones discusses how clinical features, genomic risk, and patient priorities inform treatment planning in early-stage HR-positive/HER2-negative breast cancer, including...
Episode #51
In this episode of OncoTalks, host Dr. Ira Zackon welcomes Dr. Brad Christensen to discuss how mature clinical trial data are influencing treatment selection and patient management in CLL. Together, they explore the...
Episode #49
Adherence starts long before the first missed dose. In this episode, Dr. Brad Christensen shares real-world insights on helping patients with chronic lymphocytic leukemia (CLL) stay on BTK inhibitor therapy over the...
Episode #48
In the final installment, Dr. Luke Fletcher shares strategies for managing resistant chronic myeloid leukemia (CML), including adverse event monitoring, supportive care, and response-based dose optimization to improve...
Episode #47
Dr. Luke Fletcher discusses mutation testing in chronic myeloid leukemia (CML), including when to test, how results influence treatment decisions, and the clinical significance of mutations such as T315I. This episode...
Episode #46
Dr. Luke Fletcher examines the growing role of measurable residual disease (MRD) and molecular response in treatment monitoring, and the impact of tyrosine kinase inhibitor (TKI) selection on achieving deep and durable...
Episode #45
Dr. Luke Fletcher reviews the evolving treatment approach for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), highlighting how tyrosine kinase inhibitors (TKIs) are integrated throughout...
Episode #43
Dr. Edward Pearson explores the latest advancement in anti-CD38 therapy: subcutaneous delivery of isatuximab via on-body injector. He reviews clinical evidence on efficacy, safety, and patient preference, and shares how...
Episode #42
Brook Cox, BSN, RN, OCN, an oncology nurse and infusion room supervisor, shares how subcutaneous administration of anti-CD38 therapy has transformed infusion center operations, improved patient flow, and created both...
Episode #41
Dr. Edward Pearson reviews pivotal clinical trial data supporting anti-CD38-based regimens and explores how clinicians can balance efficacy, tolerability, and quality of life when managing high-risk and...
Episode #40
Dr. Edward Pearson discusses the growing role of anti-CD38-based quadruplet therapy and key considerations influencing frontline therapy selection for patients with newly diagnosed, transplant-ineligible multiple...
Episode #44
This learning module provides a brief overview of HER2 testing in metastatic non-small cell lung, bladder, rectal, cervical, biliary tract, ovarian, pancreatic, endometrial, and colon cancers, highlighting...
Episode #39
In this episode of OncoTalks, Dr. Yair Levy shares his approach to BTKi selection for patients with chronic lymphocytic leukemia (CLL), highlighting the growing role of second-generation BTK inhibitors, and the...
Episode #38
In this episode of OncoTalks, host Tulsi Patel is joined by Dr. Yair Levy to discuss the growing impact of utilization management policies on chronic lymphocytic leukemia (CLL) care. As treatment options expand...
Episode #36
<p>Take a closer look at DLL3 as an emerging biomarker and therapeutic target in EP‑NEC. Dr. Pelster discusses the biology behind DLL3 overexpression and the latest clinical data on DLL3‑directed therapies, including...
Episode #35
<p>With limited durable options available, new approaches are urgently needed in EP-NEC. This episode highlights emerging therapies, including immunotherapy‑based strategies and early clinical trial data shaping future...
Episode #34
<p>Explore the current EP‑NEC treatment landscape, from first‑line platinum‑based therapy and etoposide to second‑line challenges. Dr. Pelster reviews guideline‑recommended options, sequencing considerations, and why...
Recent guests on OncoTalks | Oncology Insights at Your Fingertips. Study who booked and why before you pitch.
PitchCentric classifies OncoTalks | Oncology Insights at Your Fingertips under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ